We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current HQL market cap is 342.07M. The company's latest EPS is USD 3.3215 and P/E is 4.01.
| Quarter End | |||||
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | |||||
| Operating Income | |||||
| Net Income |
| Year End September 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 3.39M | 2.29M | 3.02M | 3.5M | 3.98M |
| Operating Income | 0 | 0 | 0 | 0 | 0 |
| Net Income | 123.05M | 64.53M | -104.6M | 22.35M | 85.3M |
| Quarter End | |||||
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | |||||
| Total Liabilities | |||||
| Total Equity |
| Year End September 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 484.17M | 534.19M | 414.73M | 402.6M | 460.58M |
| Total Liabilities | 596k | 10.75M | 16.82M | 666k | 889k |
| Total Equity | 483.57M | 523.44M | 397.9M | 401.93M | 459.69M |
| Market Cap | 342.07M |
| Price to Earnings Ratio | 4.01 |
| Price to Sales Ratio | 85.87 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0.74 |
| Dividend Yield | 14.71% |
| Shares Outstanding | 25.68M |
| Average Volume (1 week) | 99.21k |
| Average Volume (1 Month) | 97.34k |
| 52 Week Change | -1.03% |
| 52 Week High | 15.8999 |
| 52 Week Low | 12.76 |
| Spread (Intraday) | 0.07 (0.52%) |
| Company Name | abrdn Life Sciences Investors |
| Address |
100 federal street boston, massachusetts 02110 |
| Website | https://www.teklacap.com/hql.html |
| Industry | unit inv tr, closed-end mgmt (6726) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
